Haleon plc (LON:HLN)

Market Cap	35.11B +0.9%
Revenue (ttm)	11.03B -1.8%
Net Income	1.67B +15.6%
EPS	0.19 +17.8%
Shares Out	8.91B
PE Ratio	21.31
Forward PE	19.18
Dividend	0.07 (1.73%)
Ex-Dividend Date	n/a

Volume	10,725,016
Average Volume	17,720,260
Open	396.20
Previous Close	394.20
Day's Range	393.80 - 399.90
52-Week Range	274.40 - 419.50
Beta	0.22
RSI	50.30
Earnings Date	Feb 25, 2026

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprisi...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1715
• Employees: 24,561
• Stock Exchange: London Stock Exchange
• Ticker Symbol: HLN

Financial Performance

In 2025, Haleon's revenue was 11.03 billion, a decrease of -1.81% compared to the previous year's 11.23 billion. Earnings were 1.67 billion, an increase of 15.60%.